SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Spectrum Pharmaceutecals, Inc. (SPPI)

SPPI RSS Feed
Add SPPI Price Alert      Hide Sticky   Hide Intro
Moderator: Ville7, antihama
Search This Board: 
Last Post: 9/22/2017 9:02:20 AM - Followers: 76 - Board type: Free - Posts Today: 0

http://www.spectrumpharm.com/

http://finance.yahoo.com/q/ks?s=SPPI+Key+Statistics

Company Presentation

http://www.sppirx.com/704-corporate-presentation.html

Spectrum Development Pipeline/Portfolio

Fusilev® (Levoleucovorin) for injection FDA Approved on April 29, 2011 for Use in Patients with Advanced Metastatic Colorectal Cancer and FDA Approved on March 7, 2008 for High-Dose Methotrexate Rescue Therapy in Osteosarcoma.
Zevalin® (ibritumomab tiuxetan), an FDA-Approved, Proprietary, Biological Drug for Indolent Non-Hodgkin's Lymphoma.
Belinostat a novel HDAC inhibitor in late stage clinical development for Peripheral T-cell Lymphoma, and other Solid Tumors (including Carcinoma of Unknown Primary, etc.)
Apaziquone, one of our lead development candidates, is a synthetic bio-reductive prodrug that is being investigated in the treatment of non-invasive bladder cancer, and began two Phase 3 studies in 2007.Spectrum also has three drugs in the Phase 2 stage of development: Ozarelix, for the treatment of prostate cancer and Ortataxel, for the treatment of taxane-refractory tumors.
The Company has three drugs in the Phase 1 stage of development: SPI-1620, an adjunct to chemotherapy, Elsamitrucin, which will target advanced solid tumors and Lucanthone, a chemotherapy sensitizer in the treatment of recurrent, malignant brain tumors.
Other drugs in development include SPI-014, used in the treatment of hyperphosphotemia in end stage renal disease (ESRD), and SPI-205 for chemotherapy induced neuropathy.

Recent News (Zevalin):

http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632354
http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632346

.  

 

SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
SPPI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPPI News: Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September 09/05/2017 07:00:00 AM
SPPI News: Spectrum Pharmaceuticals to Present Corporate Update at the 2017 Southern California Investor Conference in Newport Beach on ... 08/17/2017 07:00:00 AM
SPPI News: Spectrum Pharmaceuticals Announces Initiation of the Registrational Phase 3 Trial of Qapzola™ (apaziquone) in Patients with... 08/14/2017 07:00:00 AM
SPPI News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 08/04/2017 05:11:32 PM
SPPI News: Current Report Filing (8-k) 08/04/2017 05:08:30 PM
PostSubject
#1776   Appreciate your response. FOODINI 09/22/17 09:02:20 AM
#1775   That's the way I thought about it, a antihama 09/22/17 07:52:55 AM
#1774   Any imput into the 4 million share block FOODINI 09/21/17 05:39:23 PM
#1773   Mystery solved regarding CASI's SP rise. CEO buying! antihama 09/20/17 06:21:04 PM
#1772   It is usual for scientific conferences that the Ville 09/20/17 12:21:46 PM
#1771   Good move SPPI not going the biosimilar route. antihama 09/19/17 04:45:13 PM
#1770   While I can't wait for the abstract, I antihama 09/19/17 03:50:32 PM
#1769   I just checked. SPPI owns ~10M shares at antihama 09/19/17 02:42:34 PM
#1768   antihama, the 20% in CASI was diluted in Ville 09/19/17 01:50:22 PM
#1767   poziotinib NSCLC exon-20 trial interim data: abstract at Ville 09/19/17 01:47:04 PM
#1766   Up another 25% yesterday on 20x the volume. antihama 09/19/17 07:38:36 AM
#1765   CASI just added ~$6M to SPPIs Balance Sheet. antihama 09/15/17 05:35:17 PM
#1764   Looks like Mylan’s Neulasta biosimilar may be delayed. antihama 09/15/17 03:32:51 PM
#1763   Just found another SPI-2012 PK study (NCT01037543) that antihama 09/14/17 02:46:31 PM
#1762   Several takeaways from the last two CCs. antihama 09/13/17 04:27:49 PM
#1761   OK, back to my home computer w my antihama 09/11/17 06:08:28 PM
#1760   IASLC 2017 poziotionib MD Anderson trial - first data Ville7 09/11/17 01:52:06 AM
#1759   Hi antihama, Ville 09/10/17 06:23:06 PM
#1758   Only 1 death in 94 pts with the antihama 09/10/17 12:28:32 PM
#1757   Yeah, reading about the pts on INSPIRE sure antihama 09/10/17 12:08:53 PM
#1756   another poziotinib slide - korean bc study Ville7 09/10/17 10:27:49 AM
#1755   MD Anderson - clinical trial exon-20 poziotinib - Ville7 09/10/17 10:22:25 AM
#1754   Poziotinib Slides - ESMO 2017 - Hanmi study bc Ville7 09/10/17 09:42:36 AM
#1753   20 USD Ville7 09/08/17 06:24:12 AM
#1752   Hey, a third Seeking Alpha article on SPPI antihama 09/06/17 05:01:11 PM
#1751   One other big difference besides double dosing is antihama 08/31/17 01:38:02 PM
#1750   Thanks Ville, you know I had my doubts antihama 08/31/17 08:18:30 AM
#1749   the = they Ville 08/31/17 04:03:23 AM
#1748   PFS 4.04 months, DCR 75.49%, ORR 18.8% Ville 08/31/17 03:58:55 AM
#1747   2017 California Investor Conference antihama 08/25/17 08:26:11 AM
#1746   And Complete as of 7/20/17. antihama 08/23/17 10:27:39 PM
#1744   Regarding Spectrum currently holds a Zacks Rank #2 antihama 08/22/17 06:47:31 PM
#1743   Breast cancer P2 Poziotinib info from 2015 SABCS. antihama 08/18/17 03:56:05 PM
#1742   Spectrum currently holds a Zacks Rank #2 (Buy)! antihama 08/17/17 07:55:07 AM
#1741   future stock price should be at least $14.20 antihama 08/16/17 07:57:21 AM
#1740   H.C. Wainwright ups SPPI price target to $14 antihama 08/16/17 07:47:21 AM
#1739   Selling Rolontis Do’s and Don’ts once approved. This antihama 08/15/17 12:34:12 PM
#1738   The PR for start of Qapzola Patient enrollment antihama 08/15/17 11:45:41 AM
#1737   New SA article, second one in a month. antihama 08/08/17 06:20:45 PM
#1736   Ziggy, a realistic near future stock price is… antihama 08/07/17 03:39:38 PM
#1735   what do you think a realistic near future Zippyry 08/06/17 10:58:21 AM
#1734   Correction - Getting 5M later this year for antihama 08/06/17 08:09:49 AM
#1733   2nd Q PR and CC impressions. As previously antihama 08/05/17 03:59:59 PM
#1732   Poziotinib - most exciting cancer drug results seen Just Jack 08/04/17 03:19:45 PM
#1731   I've been away from my computer since before antihama 08/04/17 12:47:11 PM
#1730   "So i expect SPPI to go higher from Ville7 08/04/17 10:02:01 AM
#1729   expected newsflow ( (c) Ville ): Ville7 08/04/17 06:23:23 AM
#1728   Just when the call started, I had to antihama 08/03/17 05:56:07 PM
#1727   Did they mention the Hanmi "proffered paper" in Ville7 08/03/17 05:45:23 PM
#1726   Q2 $34.3M Revenue beats by $3.8M;EPS beats by $0.16. antihama 08/03/17 04:30:26 PM
PostSubject